SNDY dd-sheet. OTC/markets Solos Endos
Post# of 40255
Posted On: 02/22/2013 11:17:20 AM
Re: trooperstocks #2
SNDY dd-sheet.
OTC/markets
Solos Endoscopy and TUV SUD America Schedule Stage 1 ISO 13485 Audit for February 26, 2013
1/16/12 Solos Endoscopy Finishes 2012 Strong
11/15/12 financial results for the period ended September 30 , 2012. Solos Endoscopy posted total assets of $2,490,394 compared to total liabilities of just $96,872 for the same period. As a result the Company has net assets or a book value of $2,393,522 .
9/27/12 Celebrates 25 Years of Quality Innovative HealthCare for the Multi-Billion Dollar Endoscopic Market
8/16/12 Solos Endoscopy posted Total Assets of $2,426,883 compared to Total Liabilities of just $214,827 for the same period.
7/13/12 Solos Endoscopy Begins Marketing the New SteriTAP(TM) Endoscopic Instrument Line
6/19/12 Solos Endoscopy to Expand Internationally its MammoView® Breast Endoscopy Product Line
6/13/12 Solos Endoscopy Reduces Inventory Cost and Improves Gross Profit Margin for Second Quarter 2012
5/16/12 Solos Endoscopy Posts Net Profit for First Quarter 2012
4/25/12 Solos Endoscopy Reduces Liabilities by More than $570,000
3/30/12 Solos Endoscopy Reduces Net Loss by More Than $688,000
2/2/12 Solos Endoscopy, Inc. Successfully Completes Level I FDA Inspection
2/14/12 Retirement of 150 Million Common Shares
12-29-2011 Solos Endoscopy, Inc. is Primed for Growth in 2012
Mammoview ®
Complete Camera Systems
Cameras & Accessories
Endoscopic Instruments
I llumination
Instrument Handles
Insufflation
Laparoscopic Instruments
Rigid Scopes & Accessories
SteriTAP™
Trocars & Cannulas
Veterinary Instrumentation
Video Carts
Investor's HTML / FAQ's / Contact
OTC/markets
Solos Endoscopy and TUV SUD America Schedule Stage 1 ISO 13485 Audit for February 26, 2013
1/16/12 Solos Endoscopy Finishes 2012 Strong
11/15/12 financial results for the period ended September 30 , 2012. Solos Endoscopy posted total assets of $2,490,394 compared to total liabilities of just $96,872 for the same period. As a result the Company has net assets or a book value of $2,393,522 .
9/27/12 Celebrates 25 Years of Quality Innovative HealthCare for the Multi-Billion Dollar Endoscopic Market
8/16/12 Solos Endoscopy posted Total Assets of $2,426,883 compared to Total Liabilities of just $214,827 for the same period.
7/13/12 Solos Endoscopy Begins Marketing the New SteriTAP(TM) Endoscopic Instrument Line
6/19/12 Solos Endoscopy to Expand Internationally its MammoView® Breast Endoscopy Product Line
6/13/12 Solos Endoscopy Reduces Inventory Cost and Improves Gross Profit Margin for Second Quarter 2012
5/16/12 Solos Endoscopy Posts Net Profit for First Quarter 2012
4/25/12 Solos Endoscopy Reduces Liabilities by More than $570,000
3/30/12 Solos Endoscopy Reduces Net Loss by More Than $688,000
2/2/12 Solos Endoscopy, Inc. Successfully Completes Level I FDA Inspection
2/14/12 Retirement of 150 Million Common Shares
12-29-2011 Solos Endoscopy, Inc. is Primed for Growth in 2012
Mammoview ®
Complete Camera Systems
Cameras & Accessories
Endoscopic Instruments
I llumination
Instrument Handles
Insufflation
Laparoscopic Instruments
Rigid Scopes & Accessories
SteriTAP™
Trocars & Cannulas
Veterinary Instrumentation
Video Carts
Investor's HTML / FAQ's / Contact
(0)
(0)Scroll down for more posts ▼